ClinicalTrials.Veeva

Menu

Repository Study of Autosomal Dominant Polycystic Kidney Disease

T

The Rogosin Institute

Status

Withdrawn

Conditions

Autosomal Dominant Polycystic Kidney Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01988038
1305013979

Details and patient eligibility

About

The design and establishment of the Polycystic Kidney Disease (PKD) Data Repository does not require, and may be constrained by, a narrowly conceived hypothesis. However, the PKD Repository has been designed to include demographic, clinical, biochemical, and genetic data that will further explore the natural history of the disorder and assess the factors that are likely to be associated with the progression of disease and the incidence of complications including renal failure, cardiovascular disease, and stroke.

Full description

The goal of this project is to collect data from a large population of patients with PKD. Based upon the estimated prevalence of PKD (1:500 and 1:1000 live births), it is estimated that there may be 10,000 PKD patients in the New York City area. This sample size far exceeds any database established thus far. As many as 40% of affected PKD patients are reportedly unaware of a family history of this disease, in part because many patients may go undiagnosed until they present with a medical complication (e.g., hypertension, kidney failure). Furthermore, this initiative will provide an opportunity to compare data from racially diverse populations.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Males and females
  • Age 18 years and older
  • Previously diagnosed with ADPKD

Exclusion criteria

  • Inability to provide informed consent

Trial design

0 participants in 1 patient group

No treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems